Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?
Identifieur interne : 001D62 ( PubMed/Checkpoint ); précédent : 001D61; suivant : 001D63Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?
Auteurs : Mei Ling Yap [France] ; Eduardo Zubizarreta [France] ; Freddie Bray [France] ; Jacques Ferlay [France] ; Michael Barton [France]Source :
- Journal of global oncology [ 2378-9506 ] ; 2016.
Abstract
The global incidence of cancer is rising, particularly in low- and middle-income countries. Radiotherapy is an important cancer treatment in the curative and palliative setting. We aimed to estimate the global demand for and supply of radiotherapy megavoltage machines (MVMs) and assess the changes in supply and demand during the past decade.
DOI: 10.1200/JGO.2015.001545
PubMed: 28717703
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:28717703Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?</title><author><name sortKey="Yap, Mei Ling" sort="Yap, Mei Ling" uniqKey="Yap M" first="Mei Ling" last="Yap">Mei Ling Yap</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Zubizarreta, Eduardo" sort="Zubizarreta, Eduardo" uniqKey="Zubizarreta E" first="Eduardo" last="Zubizarreta">Eduardo Zubizarreta</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:28717703</idno><idno type="pmid">28717703</idno><idno type="doi">10.1200/JGO.2015.001545</idno><idno type="wicri:Area/PubMed/Corpus">002179</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002179</idno><idno type="wicri:Area/PubMed/Curation">002153</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002153</idno><idno type="wicri:Area/PubMed/Checkpoint">002153</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002153</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?</title><author><name sortKey="Yap, Mei Ling" sort="Yap, Mei Ling" uniqKey="Yap M" first="Mei Ling" last="Yap">Mei Ling Yap</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Zubizarreta, Eduardo" sort="Zubizarreta, Eduardo" uniqKey="Zubizarreta E" first="Eduardo" last="Zubizarreta">Eduardo Zubizarreta</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name><affiliation wicri:level="3"><nlm:affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></analytic><series><title level="j">Journal of global oncology</title><idno type="ISSN">2378-9506</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The global incidence of cancer is rising, particularly in low- and middle-income countries. Radiotherapy is an important cancer treatment in the curative and palliative setting. We aimed to estimate the global demand for and supply of radiotherapy megavoltage machines (MVMs) and assess the changes in supply and demand during the past decade.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28717703</PMID><DateCreated><Year>2017</Year><Month>07</Month><Day>18</Day></DateCreated><DateRevised><Year>2017</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2378-9506</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of global oncology</Title><ISOAbbreviation>J Glob Oncol</ISOAbbreviation></Journal><ArticleTitle>Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?</ArticleTitle><Pagination><MedlinePgn>207-215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1200/JGO.2015.001545</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The global incidence of cancer is rising, particularly in low- and middle-income countries. Radiotherapy is an important cancer treatment in the curative and palliative setting. We aimed to estimate the global demand for and supply of radiotherapy megavoltage machines (MVMs) and assess the changes in supply and demand during the past decade.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Cancer incidences for 27 cancer types in 184 countries were extracted from the International Agency for Research on Cancer GLOBOCAN database. The Collaboration for Cancer Outcomes Research and Evaluation radiotherapy utilization rate (RTU) model was used to estimate the number of patients in each country with an indication for radiotherapy for each cancer type and estimate the demand for MVMs. The radiotherapy supply data were accessed from Directory of Radiotherapy Centres database maintained by the International Atomic Energy Agency.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">RTU varied by country, from 32% in Mongolia to 59% in Comoros. The average optimal world RTU was 50%, equating to 7 million people in 2012 who would benefit from radiotherapy. There remains a deficit of more than 7,000 machines worldwide. During the past decade, the gap between radiotherapy demand and supply has widened in low-income countries.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">RTU varies significantly between countries. Approximately half of all patients with cancer worldwide should receive radiotherapy; however, more than 2 million people are unable to access it because of a lack of MVMs. Low- and middle-income countries are particularly disadvantaged by this deficit.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yap</LastName><ForeName>Mei Ling</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubizarreta</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bray</LastName><ForeName>Freddie</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferlay</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>and , Ingham Institute for Applied Medical Research, University of New South Wales Australia, Liverpool, New South Wales, Australia; , International Atomic Energy Agency, Vienna, Austria; and and , International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Glob Oncol</MedlineTA><NlmUniqueID>101674751</NlmUniqueID><ISSNLinking>2378-9506</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2015 Mar 1;136(5):E359-86</RefSource><PMID Version="1">25220842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2010 Feb;11(2):165-73</RefSource><PMID Version="1">20005175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2014 Aug;112(2):155-64</RefSource><PMID Version="1">25443859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2006 Jul;7(7):584-95</RefSource><PMID Version="1">16814210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Aug;13(8):790-801</RefSource><PMID Version="1">22658655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2010 Apr;95(1):129-32</RefSource><PMID Version="1">20223541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):448-57</RefSource><PMID Version="1">24751411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):1-6</RefSource><PMID Version="1">25195984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2005 Sep 15;104(6):1129-37</RefSource><PMID Version="1">16080176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Australas Radiol. 2003 Sep;47(3):274-8</RefSource><PMID Version="1">12890248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2014 Jul;112(1):140-4</RefSource><PMID Version="1">24833561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2014 Aug;15(9):926</RefSource><PMID Version="1">25225687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Oct 2;376(9747):1186-93</RefSource><PMID Version="1">20709386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 Apr;14(4):e168-75</RefSource><PMID Version="1">23561748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2004 Jun;71(3):347-55</RefSource><PMID Version="1">15172152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):443-5</RefSource><PMID Version="1">24929152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2009 Nov;93(2):368-71</RefSource><PMID Version="1">19748141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2013 Mar 1;132(5):1133-45</RefSource><PMID Version="1">22752881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2015 Sep;16(10):1153-86</RefSource><PMID Version="1">26419354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Apr;23 Suppl 3:66-9</RefSource><PMID Version="1">22628419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Urol. 2008 Jun;15(3):4056-64</RefSource><PMID Version="1">18570709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2005 Jun;75(3):349-54</RefSource><PMID Version="1">15893832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2012 Sep;104(3):269-71</RefSource><PMID Version="1">22169767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Dec;23(12):3040-5</RefSource><PMID Version="1">23087162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 Feb;14(2):e79-86</RefSource><PMID Version="1">23352499</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Authors’ disclosures of potential conflicts of interest and contributions are found at the end of this article.The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or jco.ascopubs.org/site/ifc. Mei Ling YapNo relationship to discloseEduardo ZubizarretaNo relationship to discloseFreddie BrayNo relationship to discloseJacques FerlayNo relationship to discloseMichael BartonNo relationship to disclose</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>16</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>16</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28717703</ArticleId><ArticleId IdType="doi">10.1200/JGO.2015.001545</ArticleId><ArticleId IdType="pii">001545</ArticleId><ArticleId IdType="pmc">PMC5497622</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Rhône-Alpes</li></region><settlement><li>Lyon</li></settlement></list><tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Yap, Mei Ling" sort="Yap, Mei Ling" uniqKey="Yap M" first="Mei Ling" last="Yap">Mei Ling Yap</name></region><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name><name sortKey="Zubizarreta, Eduardo" sort="Zubizarreta, Eduardo" uniqKey="Zubizarreta E" first="Eduardo" last="Zubizarreta">Eduardo Zubizarreta</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D62 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001D62 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:28717703
|texte= Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:28717703" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |